1.
Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 May 2];9(6):s669. Available from: https://skin.dermsquared.com/skin/article/view/3867